Evox Therapeutics
PrivateLast Round
Series C
Feb 18, 2021
Total Funding Raised
$168.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evox Therapeutics is a biotechnology company that develops exosome-based therapeutics for the treatment of severe rare, neurological, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evox Therapeutics Comparables
Compare Evox Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ILIAS Biologics Inc. | 84% | |
| EXO Biologics | 77% | |
| VivaZome Therapeutics | 77% | |
Evox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 18, 2021 | ||||
| Convertible Debt | Jun 9, 2020 | ||||
| Grant | Mar 22, 2019 | ||||
| Grant | Nov 13, 2018 | ||||
| Grant | Oct 1, 2018 | ||||
Series B | Sep 3, 2018 |
Evox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| Innovate UK | Grant |
| UK government | Grant |
| GV | Series B, Series C |
| Cowen Private Investments | Series B, Series C |
| Duchenne UK | Grant |
| Oxford Science Enterprises | Series B, Series C, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 100% MoM to 5.5K.
- Mar 22, 2019
$2M grant received from Innovate UK and UK government.
Evox Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evox Therapeutics's valuation, stock price, and market status.